{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T19:57:45Z","timestamp":1781812665323,"version":"3.54.5"},"reference-count":30,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Chemotherapy induced peripheral neuropathy (CIPN) is a dose-limiting side effect of chemotherapy for which no prevention or cure exists. Cancer and cancer treatments can adversely affect nutritional status. Nutrition may play a role in development of CIPN, yet the relationship between nutrition and CIPN is not well understood. Common laboratory values measuring various aspects of nutrition (hemoglobin\/hematocrit, vitamin B12, calcium, and magnesium) may be associated with CIPN. The aim of this systematic review is to evaluate the empirical evidence surrounding the relationship between laboratory measures of nutrition and CIPN among persons with cancer who received neurotoxic chemotherapy drugs. We conducted an extensive review of the literature to identify articles that evaluated relationships between laboratory measures of nutrition and CIPN. A total of eleven articles satisfied the inclusion\/exclusion criteria. Participants in the studies had breast or colorectal cancer, lymphoma or multiple myeloma and were receiving a variety of neurotoxic drugs. Hemoglobin\/hematocrit, vitamin D, albumin, and magnesium were associated with CIPN. The quality of the studies ranges from fair to good. Evidence suggests that low levels of the above-mentioned tests could be associated with CIPN but additional research is needed.<\/jats:p>","DOI":"10.3390\/jcm11020355","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T09:10:36Z","timestamp":1641978636000},"page":"355","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A Systematic Review of Nutritional Lab Correlates with Chemotherapy Induced Peripheral Neuropathy"],"prefix":"10.3390","volume":"11","author":[{"given":"Cindy","family":"Tofthagen","sequence":"first","affiliation":[{"name":"Division of Nursing Science, Mayo Clinic, Jacksonville, FL 32224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Tanay","sequence":"additional","affiliation":[{"name":"Faculty of Nursing, Midwifery and Palliative Care, King\u2019s College London, London SE1 8WA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Perlman","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Mayo Clinic, Jacksonville, FL 32224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Starr","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Mayo Clinic, Jacksonville, FL 32224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Advani","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Mayo Clinic, Jacksonville, FL 32224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Sheffield","sequence":"additional","affiliation":[{"name":"Division of Nursing Science, Mayo Clinic, Jacksonville, FL 32224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Brigham","sequence":"additional","affiliation":[{"name":"Mayo Clinic Libraries, Mayo Clinic, Jacksonville, FL 32224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s43440-020-00109-y","article-title":"Chemotherapy-induced peripheral neuropathy: Part 1-current state of knowledge and perspectives for pharmacotherapy","volume":"72","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/0284186X.2014.995775","article-title":"Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives","volume":"54","author":"Ewertz","year":"2015","journal-title":"Acta Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Zaj\u0105czkowska, R., Kocot-K\u0119pska, M., Leppert, W., Wrzosek, A., Mika, J., and Wordliczek, J. (2019). Mechanisms of Chemotherapy-Induced Peripheral Neuropathy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061451"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e19029","DOI":"10.1097\/MD.0000000000019029","article-title":"Emotional distress and quality of life during folinic acid, fluorouracil, and oxaliplatin in colorectal cancer patients with and without chemotherapy-induced peripheral neuropathy: A cross-sectional study","volume":"99","author":"Hsu","year":"2020","journal-title":"Medicine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/0284186X.2018.1556804","article-title":"Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy","volume":"58","author":"Soveri","year":"2019","journal-title":"Acta Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Timmins, H.C., Mizrahi, D., Li, T., Kiernan, M.C., Goldstein, D., and Park, S.B. (2021). Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: A systematic review. J. Cancer Surviv., 1\u201315.","DOI":"10.1007\/s11764-021-00988-x"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/mus.26783","article-title":"Nutritional neuropathies","volume":"62","author":"Gwathmey","year":"2020","journal-title":"Muscle Nerve"},{"key":"ref_9","first-page":"1549","article-title":"Moinuddin Disorders associated with malabsorption of iron: A critical review","volume":"31","author":"Saboor","year":"2015","journal-title":"Pak. J. Med. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10549-020-05584-8","article-title":"Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy","volume":"180","author":"Jennaro","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/jns.12271","article-title":"Risk factors for the development of paclitaxel-induced neuropathy in breast cancer patients","volume":"23","author":"Robertson","year":"2018","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Grim, J., Ticha, A., Hyspler, R., Valis, M., and Zadak, Z. (2017). Selected Risk Nutritional Factors for Chemotherapy-Induced Polyneuropathy. Nutrients, 9.","DOI":"10.3390\/nu9060535"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000442527","article-title":"Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy","volume":"90","author":"Ottaiano","year":"2016","journal-title":"Oncology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.7314\/APJCP.2015.16.17.7603","article-title":"Prevalence of Oxaliplatin-induced Chronic Neuropathy and Influencing Factors in Patients with Colorectal Cancer in Iran","volume":"16","author":"Fahimi","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00520-012-1667-5","article-title":"Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV","volume":"21","author":"Vincenzi","year":"2013","journal-title":"Support. Care Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/01635581.2019.1637005","article-title":"Are Ergothioneine Levels in Blood Associated with Chronic Peripheral Neuropathy in Colorectal Cancer Patients Who Underwent Chemotherapy?","volume":"72","author":"Winkels","year":"2020","journal-title":"Nutr. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3727\/096504018X15267574931782","article-title":"Anemia Is a Novel Predictive Factor for the Onset of Severe Chemotherapy-Induced Peripheral Neuropathy in Lymphoma Patients Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone Therapy","volume":"27","author":"Saito","year":"2019","journal-title":"Oncol. Res."},{"key":"ref_18","first-page":"3105","article-title":"Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and\/or thalidomide and is associated with severe neuropathy","volume":"24","author":"Wang","year":"2016","journal-title":"Support. Care Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1007\/s00520-020-05319-x","article-title":"Predictive clinical factors of chronic peripheral neuropathy induced by oxaliplatin","volume":"28","author":"Yildirim","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/jns.12177","article-title":"Serum micronutrients and prealbumin during development and recovery of chemotherapy-induced peripheral neuropathy","volume":"21","author":"Velasco","year":"2016","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10571-019-00667-7","article-title":"Neuroprotective Role of Selected Antioxidant Agents in Preventing Cisplatin-Induced Damage of Human Neurons In Vitro","volume":"39","author":"Klajn","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1007\/s00520-016-3175-5","article-title":"Functional vitamin B12 deficiency in advanced malignancy: Implications for the management of neuropathy and neuropathic pain","volume":"24","author":"Solomon","year":"2016","journal-title":"Support. Care Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/biom.12816","article-title":"Discussion of \u201cquantifying publication bias in meta-analysis\u201d by Lin et al","volume":"74","author":"Schmid","year":"2018","journal-title":"Biometrics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"Lin","year":"2018","journal-title":"Biometrics"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Timmins, H.C., Li, T., Goldstein, D., Trinh, T., Mizrahi, D., Harrison, M., Horvath, L.G., Friedlander, M., Kiernan, M.C., and Park, S.B. (2021). The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors. J. Cancer Surviv., 1\u201310.","DOI":"10.1007\/s11764-021-01012-y"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e2036695","DOI":"10.1001\/jamanetworkopen.2020.36695","article-title":"Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy","volume":"4","author":"Mizrahi","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0145721711410717","article-title":"Diabetic neuropathy status and the concerns in underserved rural communities: Challenges and opportunities for diabetes educators","volume":"37","author":"Wang","year":"2011","journal-title":"Diabetes Educ."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Nyrop, K.A., Damone, E.M., Deal, A.M., Wheeler, S.B., Charlot, M., Reeve, B.B., Basch, E., Shachar, S.S., Carey, L.A., and Reeder-Hayes, K.E. (2021). Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer. Breast Cancer Res. Treat., 1\u201314.","DOI":"10.1007\/s10549-021-06439-6"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/cam4.25","article-title":"Analysis of neurosensory adverse events induced by FOLFOX4 treatment in colorectal cancer patients: A comparison between two Asian studies and four Western studies","volume":"1","author":"Sugihara","year":"2012","journal-title":"Cancer Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000445977","article-title":"Calcium and Magnesium Infusions for the Prevention of Oxaliplatin-Induced Peripheral Neurotoxicity: A Systematic Review","volume":"90","author":"Jordan","year":"2016","journal-title":"Oncology"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/2\/355\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:14:58Z","timestamp":1760364898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/2\/355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,12]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["jcm11020355"],"URL":"https:\/\/doi.org\/10.3390\/jcm11020355","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,12]]}}}